Fisiopatología de la insuficiencia cardíaca / Pathophysiology of heart failure
Arch. cardiol. Méx
;
76(supl.2): S182-S187, abr.-jun. 2006.
Artigo
em Espanhol
| LILACS
| ID: lil-568824
ABSTRACT
Treatment of heart failure has been successfully target biologically, to counteract deleterious effects resulting from neuroendocrine activation, with the use of several agents (e.g., angiotensine-converting enzyme inhibitors, beta-adrenergic receptor blockers, spironolactone), that provide benefical effects, demonstrated in multicentric trials in controlled populations. However, this mid-term benefit, becomes less effective with time, resulting in progression of the disease to terminal stages and death. The purpose of this paper is to review other pathophysiologic pathways and the potential application of preventive measures to be incorporated in the standardized treatment of heart failure.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Insuficiência Cardíaca
Limite:
Humanos
Idioma:
Espanhol
Revista:
Arch. cardiol. Méx
Assunto da revista:
Cardiologia
Ano de publicação:
2006
Tipo de documento:
Artigo
País de afiliação:
México
Instituição/País de afiliação:
INCICH/MX
Similares
MEDLINE
...
LILACS
LIS